109 related articles for article (PubMed ID: 29045948)
1. Impact of Gastric Cancer Surgery in Elderly Patients.
Wakahara T; Ueno N; Maeda T; Kanemitsu K; Yoshikawa T; Tsuchida S; Toyokawa A
Oncology; 2018; 94(2):79-84. PubMed ID: 29045948
[TBL] [Abstract][Full Text] [Related]
2. Validity of Laparoscopic Gastrectomy in the Elderly.
Wakahara T; Kanemitsu K; Maeda T; Yoshikawa T; Tsuchida S; Ueno N; Toyokawa A
Oncology; 2019; 96(2):87-92. PubMed ID: 30278437
[TBL] [Abstract][Full Text] [Related]
3. A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE).
Mizutani T; Yamaguchi K; Mizusawa J; Ito S; Nishida Y; Yabusaki H; Boku N; Sano T; Yoshida K; Sasako M; Yoshikawa T; Terashima M;
Jpn J Clin Oncol; 2018 Dec; 48(12):1101-1104. PubMed ID: 30346560
[TBL] [Abstract][Full Text] [Related]
4. Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
Cho JH; Lim JY; Cho JY
PLoS One; 2017; 12(10):e0186362. PubMed ID: 29040299
[TBL] [Abstract][Full Text] [Related]
5. Palliative gastrectomy in patients with stage IV gastric cancer--our recent experience.
Lupaşcu C; Andronic D; Ursulescu C; Vasiluţă C; Raileanu G; Georgescu St; Niculescu D; Crumpei F; Târcoveanu E
Chirurgia (Bucur); 2010; 105(4):473-6. PubMed ID: 20941968
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy.
Jin Y; Qiu MZ; Wang DS; Zhang DS; Ren C; Bai L; Luo HY; Wang ZQ; Wang FH; Li YH; Xu RH
PLoS One; 2013; 8(1):e53149. PubMed ID: 23359796
[TBL] [Abstract][Full Text] [Related]
7. Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy.
Feng WM; Tang CW; Guo HH; Bao Y; Fei MY
Biomed Pharmacother; 2015 May; 72():140-3. PubMed ID: 26054688
[TBL] [Abstract][Full Text] [Related]
8. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
9. Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
Shin HB; An JY; Lee SH; Choi YY; Kim JW; Sohn SS; Noh SH
BMC Cancer; 2017 Apr; 17(1):287. PubMed ID: 28431518
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics and Prognoses of Elderly Gastric Cancer Patients after R0 Resection: A Multicenter Study in China.
Ma X; Ren D; Kan J; Zheng F; Zhang S; Zhang Y; Li Y; Liu Z; Ye L; Shen G; Wang Z; Zhao F; Ahmad R; Zhao J
J Environ Pathol Toxicol Oncol; 2018; 37(1):81-91. PubMed ID: 29773002
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
12. The Role of Adjuvant Chemotherapy for Patients with Stage IB Gastric Cancer.
Toyokawa T; Ohira M; Sakurai K; Kubo N; Tanaka H; Muguruma K; Hirakawa K
Anticancer Res; 2015 Jul; 35(7):4091-7. PubMed ID: 26124360
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Effectiveness of Gastrectomy for Elderly Gastric Cancer Patients.
Otowa Y; Okamoto S; Fujinaka R; Arai K; Murata K; Mii Y; Kakinoki K; Oka S; Kuroda D
In Vivo; 2019; 33(4):1307-1311. PubMed ID: 31280223
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer in the elderly: an overview.
Saif MW; Makrilia N; Zalonis A; Merikas M; Syrigos K
Eur J Surg Oncol; 2010 Aug; 36(8):709-17. PubMed ID: 20542657
[TBL] [Abstract][Full Text] [Related]
16. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
[TBL] [Abstract][Full Text] [Related]
18. Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines
Moon JH; Fujiwara Y; Hirao M; Imamura H; Kimura Y; Fujitani K; Fujita J; Tamura S; Takiguchi S; Yano M; Mori M; Doki Y
Anticancer Res; 2017 Jun; 37(6):3061-3067. PubMed ID: 28551645
[TBL] [Abstract][Full Text] [Related]
19. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
